Issue 25-5, 2026

Original article

Obesity and Sarcopenic Obesity in Older Adults: Specifics of Geriatric Status and Cardiorespiratory Fitness (A Prospective Controlled Study)



ORCIDMariia S. Arefeva*, ORCIDElena A. Kolesnikova, ORCIDKsenia A. Eruslanova, ORCIDValentina S. Ostapenko, ORCIDNadezda K. Runikhina, ORCIDOlga N. Tkacheva

Pirogov Russian National Research Medical University, Moscow, Russia


ABSTRACT

INTRODUCTION. The absence of well-defined diagnostic criteria and a general lack of awareness regarding the symptoms of sarcopenic obesity (SO) in older adults hinder prompt diagnosis. This underscores the need for research into its prevalence and clinical-functional traits to devise tailored management strategies.

AIM. To identify differences in clinical and functional characteristics (including an assessment of cardiorespiratory fitness based on cardiorespiratory exercise testing), metabolic and socio-demographic characteristics between patients aged ≥ 60 years with and without obesity; and, within the obese group, to compare subgroups with SO and obesity without sarcopenia to define phenotypic markers.

MATERIALS AND METHODS. The study was conducted at the Russian Clinical and Research Center of Gerontology from 2024 to 2026. Data from 109 patients (72.2 ± 6.88 years; 75.2 % female; 24.8 % male; 46.8 % obesity; 42.2 % frailty) were analyzed. All underwent comprehensive geriatric assessment, bioelectrical impedance analysis, cardiopulmonary exercise testing. The formed groups included: patients with obesity (n = 51; 72.0 ± 6.26 years; 80.4 % female) and without obesity (n = 58; 72.3 ± 7.44 years; 70.7 % female). Among obesity patients, SO (n = 13; 75.7 ± 8.21 years; 100 % female) and Non-SO (n = 38; 71.1 ± 6.59 years; 74.4 % female) were identified.

RESULTS. In obesity group, compared to non-obese patients, we observed lower cardiorespiratory fitness (peak oxygen consumption 14.29 ± 5.13 mL/kg/min vs 17.78 ± 5.17 mL/kg/min; p < 0.001), decreased strength index (p < 0.01) and mobility (p < 0.05), metabolic deterioration (hypertriglyceridemia, hyperglycemia, hyperuricemia, low high-density lipoprotein cholesterol) (p < 0.05), increased left atrial volume (p < 0.01). The proportion of SO among patients with obesity was 25.5 %.

DISCUSSION. In comparison the SO and non-SO groups revealed significant differences (p < 0.05) across all analyzed parameters, including functional tests, cardiorespiratory fitness, cognitive and social status, lab markers, Charlson Comorbidity Index, and quality of life.

CONCLUSION. Obesity in elderly is associated with reduced cardiorespiratory fitness, functional performance, metabolic profile deterioration. Sarcopenic obesity represents the most vulnerable phenotype with lower cardiorespiratory reserves and muscle strength, more severe geriatric status compared to non-SO; it is found in almost one in four patients with obesity, which necessitates active screening for SO and comprehensive, multidisciplinary management.


KEYWORDS: cardiopulmonary exercise testing, frailty, comprehensive geriatric assessment, sarcopenic obesity, obesity, sarcopenia

FOR CITATION: Arefeva M.S., Kolesnikova E.A., Eruslanova K.A., Ostapenko V.S., Runikhina N.K., Tkacheva O.N. Obesity and Sarcopenic Obesity in Older Adults: Specifics of Geriatric Status and Cardiorespiratory Fitness (A Prospective Controlled Study). Bulletin of Rehabilitation Medicine. 2026; 25(5):70–82. https://doi.org/10.38025/2078-1962-2026-25-5-70-82 (In Russ.).

FOR CORRESPONDENCE:

Mariia S. Arefeva, E-mail: arefieva_ms@rgnkc.ru


References:

  1. American Diabetes Association Professional Practice Committee for Obesity. Screening, diagnosis, evaluation, and staging of obesity in adults: Standards of Care in Overweight and Obesity-2026. BMJ Open Diabetes Res Care. 2026; 13(Suppl 1): e006247. https://doi.org/10.1136/bmjdrc-2026-006247
  2. Maffiuletti N.A., Ratel S., Sartorio A., et al. The impact of obesity on in vivo human skeletal muscle function. Curr Obes Rep. 2013; 2(3): 251–260. https://doi.org/10.1007/s13679-013-0066-7
  3. Dent E., Morley J.E., Cruz-Jentoft A.J., et al. International Clinical Practice Guidelines for Sarcopenia (ICFSR): screening, diagnosis and management. J Nutr Health Aging. 2018; 22(10): 1148–1161. https://doi.org/10.1007/s12603-018-1139-9
  4. Donini L.M., Busetto L., Bischoff S.C., et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement. Obes Facts. 2022; 15(3): 321–335. https://doi.org/10.1159/000521241
  5. Batsis J.A., Barre L.K., Mackenzie T.A., et al. Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999–2004. J Am Geriatr Soc. 2013; 61(6): 974–980. https://doi.org/10.1111/jgs.12260
  6. Damanti S., Citterio L., Zagato L., et al. Sarcopenic obesity and pre-sarcopenia contribute to frailty in community-dwelling Italian older people: data from the FRASNET study. BMC Geriatr. 2024; 24(1): 638. https://doi.org/10.1186/s12877-024-05216-6
  7. Kanda H., Tateya S., Tamori Y., et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest. 2006; 116: 1494–1505. https://doi.org/10.1172/JCI26498
  8. Chen Y.F., Lee C.W., Wu H.H., et al. Immunometabolism of macrophages regulates skeletal muscle regeneration. Front Cell Dev Biol. 2022; 10: 948819. https://doi.org/10.3389/fcell.2022.948819
  9. Jiang H., Zhang Y., Luo Z., et al. Immunometabolic mechanisms of osteosarcopenic obesity: chronic inflammation, trained immunity, and systemic immune dysregulation. Front Immunol. 2026; 17: 1808488. https://doi.org/10.3389/fimmu.2026.1808488
  10. Ono T., Hayashi M., Sasaki F., et al. RANKL biology: bone metabolism, the immune system, and beyond. Inflamm Regen. 2020; 40: 2. https://doi.org/10.1186/s41232-019-0111-3
  11. Aryana I.G.P.S., Paulus I.B., Kalra S., et al. The important role of intermuscular adipose tissue on metabolic changes interconnecting obesity, ageing and exercise: a systematic review. touchREV Endocrinol. 2023; 19(1): 54–59. https://doi.org/10.17925/EE.2023.19.1.54
  12. Арефьева М.С., Колесникова Е.А., Рунихина Н.К. и др. Возможности персонализации физической реабилитации по результатам кардиореспираторного нагрузочного тестирования для гериатрических пациентов: обзор. Вестник восстановительной медицины. 2026; 25(2): 77–90. https://doi.org/10.38025/2078-1962-2026-25-2-77-90 [Arefeva M.S., Kolesnikova E.A., Runikhina N.K., et al. Personalizing Physical Rehabilitation for Geriatric Patients Using Cardiorespiratory Exercise Testing: A Review. Bulletin of Rehabilitation Medicine. 2026; 25(2): 77–90. https://doi.org/10.38025/2078-1962-2026-25-2-77-90 (In Russ.).]
  13. Billingsley H.E., Del Buono M.G., Canada J.M., et al. Sarcopenic obesity is associated with reduced cardiorespiratory fitness compared with nonsarcopenic obesity in patients with heart failure with reduced ejection fraction. Circ Heart Fail. 2022; 15(10): e009518. https://doi.org/10.1161/CIRCHEARTFAILURE.122.009518
  14. Deng S., Mei S., Zhou Q., et al. Characteristics of cardiopulmonary exercise capacity in adults with different degrees of obesity. Front Physiol. 2025; 15: 1466153. https://doi.org/10.3389/fphys.2024.1466153
  15. Villareal D.T., Apovian C.M., Kushner R.F., et al. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, The Obesity Society. Am J Clin Nutr. 2005; 82(5): 923–934. https://doi.org/10.1093/ajcn/82.5.923
  16. Sharma A., Lytle K.A., Jensen M.D. Relationship between aerobic fitness and adipose tissue insulin resistance. Am J Physiol Endocrinol Metab. 2026; 330(1): E81–E87. https://doi.org/10.1152/ajpendo.00327.2025
  17. Cui N., Li Q., Cheng J., et al. Association Between Metabolic Syndrome and Cardiac Autonomic Nervous Function and Cardiorespiratory Fitness in Older Adults: A Retrospective Observational Study with Propensity Score Overlap Weighting. Clin Interv Aging. 2025; 20: 93–105. https://doi.org/10.2147/CIA.S489409
  18. Fico B.G., Maharaj A., Pena G.S., et al. The Effects of Obesity on the Inflammatory, Cardiovascular, and Neurobiological Responses to Exercise in Older Adults. Biology (Basel). 2023; 12(6): 865. https://doi.org/10.3390/biology12060865
  19. Cruz-Jentoft A.J., Bahat G., Bauer J., et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019; 48(1): 16–31. https://doi.org/10.1093/ageing/afy169
  20. Baumgartner R.N., Wayne S.J., Waters D.L., et al. Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly. Obes Res. 2004; 12(12): 1995–2004. https://doi.org/10.1038/oby.2004.250
  21. Saito H., Matsue Y., Kamiya K., et al. Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF. BMC Geriatr. 2022; 22(1): 556. https://doi.org/10.1186/s12877-022-03168-3
  22. Wolf C., Blackwell T.L., Johnson E., et al. Cardiopulmonary Exercise Testing in a Prospective Multicenter Cohort of Older Adults. Med Sci Sports Exerc. 2024; 56(9): 1574–1584. https://doi.org/10.1249/MSS.0000000000003444
  23. Myers J., Prakash M., Froelicher V., et al. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002; 346(11): 793–801. https://doi.org/10.1056/NEJMoa011858
  24. Colleluori G., Villareal D.T. Weight strategy in older adults with obesity: calorie restriction or not? Curr Opin Clin Nutr Metab Care. 2023; 26(1): 17–22. https://doi.org/10.1097/MCO.0000000000000879
  25. von Haehling S., Langer H.T., Heymsfield S.B., et al. Sarcopenia in Ageing and Chronic Illness: Trial Endpoints and Regulatory Issues. J Cachexia Sarcopenia Muscle. 2025; 16(3): e13841. https://doi.org/10.1002/jcsm.13841



Creative Commons License
The content is available under the Creative Commons Attribution 4.0 License.

©


This is an open article under the CC BY 4.0 license. Published by the National Medical Research Center for Rehabilitation and Balneology.